Literature DB >> 25923830

Paradoxical effect of dopamine medication on cognition in Parkinson's disease: relationship to side of motor onset.

Brenda Hanna-Pladdy1, Rajesh Pahwa2, Kelly E Lyons2.   

Abstract

Parkinson's disease (PD) is characterized by asymmetric motor symptom onset attributed to greater degeneration of dopamine neurons contralateral to the affected side. However, whether motor asymmetries predict cognitive profiles in PD, and to what extent dopamine influences cognition remains controversial. This study evaluated cognitive variability in PD by measuring differential response to dopamine replacement therapy (DRT) based on hemispheric asymmetries. The influence of DRT on cognition was evaluated in mild PD patients (n = 36) with left or right motor onset symptoms. All subjects were evaluated on neuropsychological measures on and off DRT and compared to controls (n = 42). PD patients were impaired in executive, memory and motor domains irrespective of side of motor onset, although patients with left hemisphere deficit displayed greater cognitive impairment. Patients with right hemisphere deficit responded to DRT with significant improvement in sensorimotor deficits, and with corresponding improvement in attention and verbal memory functions. Conversely, patients with greater left hemisphere dopamine deficiency did not improve in attentional functions and declined in verbal memory recall following DRT. These findings support the presence of extensive mild cognitive deficits in early PD not fully explained by dopamine depletion alone. The paradoxical effects of levodopa on verbal memory were predicted by extent of fine motor impairment and sensorimotor response to levodopa, which reflects extent of dopamine depletion. The findings are discussed with respect to factors influencing variable cognitive profiles in early PD, including hemispheric asymmetries and differential response to levodopa based on dopamine levels predicting amelioration or overdosing.

Entities:  

Keywords:  Cognition; Dopamine; Memory; Motor asymmetry; Parkinson’s disease

Mesh:

Substances:

Year:  2015        PMID: 25923830      PMCID: PMC4493897          DOI: 10.1017/S1355617715000181

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  79 in total

1.  Taking sides: is handedness involved in motor asymmetry of Parkinson's disease?

Authors:  Eldad Melamed; Werner Poewe
Journal:  Mov Disord       Date:  2012-01-05       Impact factor: 10.338

2.  Body side of motor symptom onset in Parkinson's disease is associated with memory performance.

Authors:  M M Amick; J Grace; K L Chou
Journal:  J Int Neuropsychol Soc       Date:  2006-09       Impact factor: 2.892

3.  Side and type of motor symptom influence cognition in Parkinson's disease.

Authors:  Heather L Katzen; Bonnie E Levin; William Weiner
Journal:  Mov Disord       Date:  2006-11       Impact factor: 10.338

4.  L-dopa modulates functional connectivity in striatal cognitive and motor networks: a double-blind placebo-controlled study.

Authors:  Clare Kelly; Greig de Zubicaray; Adriana Di Martino; David A Copland; Philip T Reiss; Donald F Klein; F Xavier Castellanos; Michael P Milham; Katie McMahon
Journal:  J Neurosci       Date:  2009-06-03       Impact factor: 6.167

5.  Dopaminergic modulation of memory and affective processing in Parkinson depression.

Authors:  Lee X Blonder; John T Slevin; Richard J Kryscio; Catherine A Martin; Anders H Andersen; Charles D Smith; Frederick A Schmitt
Journal:  Psychiatry Res       Date:  2013-07-06       Impact factor: 3.222

Review 6.  Amyloid-β and τ biomarkers in Parkinson's disease-dementia.

Authors:  Mariateresa Buongiorno; Yaroslau Compta; Maria J Martí
Journal:  J Neurol Sci       Date:  2011-07-20       Impact factor: 3.181

7.  Age-related decline in dopamine transporters: analysis of striatal subregions, nonlinear effects, and hemispheric asymmetries.

Authors:  Christopher H van Dyck; John P Seibyl; Robert T Malison; Marc Laruelle; Sami S Zoghbi; Ronald M Baldwin; Robert B Innis
Journal:  Am J Geriatr Psychiatry       Date:  2002 Jan-Feb       Impact factor: 4.105

8.  Use of the Beck Depression Inventory-II with depressed geriatric inpatients.

Authors:  R A Steer; D J Rissmiller; A T Beck
Journal:  Behav Res Ther       Date:  2000-03

9.  Grooved pegboard test as a biomarker of nigrostriatal denervation in Parkinson's disease.

Authors:  Nicolaas I Bohnen; Hiroto Kuwabara; Gregory M Constantine; Chester A Mathis; Robert Y Moore
Journal:  Neurosci Lett       Date:  2007-08-06       Impact factor: 3.046

10.  Differential effects of dopaminergic therapies on dorsal and ventral striatum in Parkinson's disease: implications for cognitive function.

Authors:  Penny A Macdonald; Oury Monchi
Journal:  Parkinsons Dis       Date:  2011-03-06
View more
  13 in total

1.  Evaluation of Linguistic Markers of Word-Finding Difficulty and Cognition in Parkinson's Disease.

Authors:  Kara M Smith; Sharon Ash; Sharon X Xie; Murray Grossman
Journal:  J Speech Lang Hear Res       Date:  2018-07-13       Impact factor: 2.297

2.  Dopaminergic Basis of Spatial Deficits in Early Parkinson's Disease.

Authors:  B Hanna-Pladdy; R Pahwa; K E Lyons
Journal:  Cereb Cortex Commun       Date:  2021-06-24

3.  The Relationship between Side of Onset and Cerebral Regional Homogeneity in Parkinson's Disease: A Resting-State fMRI Study.

Authors:  Kai Li; Hong Zhao; Chun-Mei Li; Xin-Xin Ma; Min Chen; Shu-Hua Li; Rui Wang; Bao-Hui Lou; Hai-Bo Chen; Wen Su
Journal:  Parkinsons Dis       Date:  2020-06-27

4.  Dopaminergic Therapy Increases Go Timeouts in the Go/No-Go Task in Patients with Parkinson's Disease.

Authors:  Xue Q Yang; Brian Lauzon; Ken N Seergobin; Penny A MacDonald
Journal:  Front Hum Neurosci       Date:  2018-01-04       Impact factor: 3.169

Review 5.  Neuroscience learning from longitudinal cohort studies of Alzheimer's disease: Lessons for disease-modifying drug programs and an introduction to the Center for Neurodegeneration and Translational Neuroscience.

Authors:  Justin B Miller; Jeffrey Cummings; Christin Nance; Aaron Ritter
Journal:  Alzheimers Dement (N Y)       Date:  2018-07-11

6.  Effects of Parkinson's disease and dopamine on digit span measures of working memory.

Authors:  John Patrick Grogan; Lisa Emily Knight; Laura Smith; Nerea Irigoras Izagirre; Alexandra Howat; Brogan Elizabeth Knight; Anastasia Bickerton; Hanna Kristiina Isotalus; Elizabeth Jane Coulthard
Journal:  Psychopharmacology (Berl)       Date:  2018-10-12       Impact factor: 4.530

7.  Spatial disorientation and executive dysfunction in elderly nondemented patients with Parkinson's disease.

Authors:  Davide M Cammisuli; Simon Crowe
Journal:  Neuropsychiatr Dis Treat       Date:  2018-10-02       Impact factor: 2.570

8.  Tablet-Based Application for Objective Measurement of Motor Fluctuations in Parkinson Disease.

Authors:  Benjamin D Wissel; Georgia Mitsi; Alok K Dwivedi; Spyridon Papapetropoulos; Sydney Larkin; José Ricardo López Castellanos; Emily Shanks; Andrew P Duker; Federico Rodriguez-Porcel; Jennifer E Vaughan; Lilia Lovera; Ioannis Tsoulos; Athanassios Stavrakoudis; Alberto J Espay
Journal:  Digit Biomark       Date:  2018-01-09

9.  The Effect of Dopaminergic Medication on Beat-Based Auditory Timing in Parkinson's Disease.

Authors:  Daniel J Cameron; Kristen A Pickett; Gammon M Earhart; Jessica A Grahn
Journal:  Front Neurol       Date:  2016-02-22       Impact factor: 4.003

10.  Cognitive characteristics in Chinese non-demented PD patients based on gender difference.

Authors:  Ke Yang; Bo Shen; Da-Ke Li; Ying Wang; Jue Zhao; Jian Zhao; Wen-Bo Yu; Zhen-Yang Liu; Yi-Lin Tang; Feng-Tao Liu; Huan Yu; Jian Wang; Qi-Hao Guo; Jian-Jun Wu
Journal:  Transl Neurodegener       Date:  2018-07-19       Impact factor: 8.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.